Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PAVmed Inc. (PAVM : NSDQ)

• Company Description    PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City. Number of Employees: 39

• Price / Volume Information    Yesterday's Closing Price: $0.28 Daily Weekly Monthly 20 Day Moving Average: 268,663 shares Shares Outstanding: 29.67 (millions) Market Capitalization: $8.31 (millions) Beta: 1.09 52 Week High: $0.90 52 Week Low: $0.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -21.44% -24.17% 12 Week -34.90% -36.53% Year To Date -55.38% -61.26%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 MADISON AVENUE 25TH FLOOR - NEW YORK,NY 10017 USA ph: 917-813-1828 fax: - mjr@pavmed.com http://www.pavmed.com

• General Corporate Information    Officers Lishan Aklog - Chief Executive Officer and Chairman Michael J. Glennon - Vice Chairman Dennis M. McGrath - President and Chief Financial Officer Debra J. White - Director Ronald M. Sparks - Director Peer Information PAVmed Inc. (ABMD) PAVmed Inc. (DMDS) PAVmed Inc. (CPWY.) PAVmed Inc. (EQUR) PAVmed Inc. (ECIA) PAVmed Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 70387R403 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/24/26 Share - Related Items Shares Outstanding: 29.67 Most Recent Split Date: 12.00 (0.07:1) Beta: 1.09 Market Capitalization: $8.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.21 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.63 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/24/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 286.49 EPS Growth vs. Year Ago Period: 46.30% vs. Previous Quarter: -383.33% Sales Growth vs. Year Ago Period: -99.50% vs. Previous Quarter: -16.67% ROE 09/30/25 - -754.98 06/30/25 - - 03/31/25 - - ROA 09/30/25 - -19.87 06/30/25 - -20.96 03/31/25 - -42.29 Current Ratio 09/30/25 - 0.40 06/30/25 - 0.52 03/31/25 - 0.37 Quick Ratio 09/30/25 - 0.40 06/30/25 - 0.52 03/31/25 - 0.37 Operating Margin 09/30/25 - -28,337.93 06/30/25 - -811.18 03/31/25 - -814.05 Net Margin 09/30/25 - 10,672.42 06/30/25 - 7,144.80 03/31/25 - 3,711.54 Pre-Tax Margin 09/30/25 - 4,931.03 06/30/25 - 6,681.57 03/31/25 - 3,289.61 Book Value 09/30/25 - -0.05 06/30/25 - 0.18 03/31/25 - 0.74 Inventory Turnover 09/30/25 - - 06/30/25 - 1,004.67 03/31/25 - 18.08 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 12.64 06/30/25 - 10.38 03/31/25 - 4.89

Powered by Zacks Investment Research ©